MedPath

A feasibility study of real-time displays of brain activity as a treatment for symptoms in Huntington's disease

Not Applicable
Completed
Conditions
Huntington's disease
Nervous System Diseases
Huntington disease
Registration Number
ISRCTN35734205
Lead Sponsor
niversity College London Hospitals NHS Foundation Trust
Brief Summary

2018 Results article in https://pubmed.ncbi.nlm.nih.gov/29239063 results (added 28/01/2020) 2020 Results article in https://doi.org/10.1093/braincomms/fcaa049 (added 28/02/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
32
Inclusion Criteria

1. > 18 years old
2. Pre-symptomatic gene-carriers, i.e. they will carry the HD gene, but will not have been clinically diagnosed (UHDRS diagnostic score of 4 or less) at the time of enrolment, OR
3. Early-stage 1 HD patients, i.e. patients with Total Functional Capacity (TFC) score between 11-13

Exclusion Criteria

Cannot be scanned in the MRI scanner

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath